Enliven Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Enliven Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2019 to Q3 2024.
  • Enliven Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 47.3M shares, a 14.7% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 47.3M +6.05M +14.7% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 47.2M +6.02M +14.6% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 46.8M +5.68M +13.8% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 41.3M +37.7M +1057% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 41.2M +14.9M +56.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 41.2M +14.9M +56.5% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 41.1M +14.8M +56.4% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 3.57M +135K +3.93% Dec 31, 2022 10-K 2024-03-14
Q3 2022 26.3M +11.5K +0.04% Sep 30, 2022 10-Q 2022-10-25
Q2 2022 26.3M +8.38M +46.8% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 26.3M +8.67M +49.2% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 3.44M -14.1M -80.4% Dec 31, 2021 8-K 2023-06-23
Q3 2021 26.3M +8.9M +51.2% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 17.9M +586K +3.38% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 17.6M +1.04M +6.28% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 17.5M +16.8M +2398% Dec 31, 2020 10-K 2022-03-15
Q3 2020 17.4M Sep 30, 2020 10-Q 2020-11-05
Q2 2020 17.3M Jun 30, 2020 10-Q 2020-08-14
Q1 2020 16.6M Mar 31, 2020 10-Q 2020-05-07
Q4 2019 703K Dec 31, 2019 10-K 2021-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.